Abstract
Ex vivo lung perfusion (EVLP) has been utilized in clinical practice for over a decade. The technique and specific devices of this emerging technology are well established and described in the literature. However, these standardized techniques have not been implemented in transplant institutes throughout the world, and only a few, large-volume centers have been utilizing EVLP to increase the donor pool because of its technical difficulty. Additionally, most transplant surgeons have high hopes that EVLP will improve early and long-term posttransplant outcomes in lung transplant recipients. Improved outcomes have not yet been demonstrated, however. This chapter describes the technical details of EVLP step-by-step, points out potential technical pitfalls, reviews the results of clinical studies and national and international clinical trials to evaluate the role and impact of EVLP in current practice, and considers the future of EVLP.
Similar content being viewed by others
References
Aboelnazar NS, Himmat S, Hatami S, White CW, Burhani MS, Dromparis P, Matsumura N, Tian G, Dyck JRB, Mengel M, Freed DH, Nagendran J (2018) Negative pressure ventilation decreases inflammation and lung edema during normothermic ex-vivo lung perfusion. J Heart Lung Transplant 37(4):520–530. https://doi.org/10.1016/j.healun.2017.09.007
Aigner C, Slama A, Hotzenecker K, Scheed A, Urbanek B, Schmid W, Nierscher FJ, Lang G, Klepetko W (2012) Clinical ex vivo lung perfusion – pushing the limits. Am J Transplant 12(7):1839–1847. https://doi.org/10.1111/j.1600-6143.2012.04027.x
Boffini M, Ricci D, Bonato R, Fanelli V, Attisani M, Ribezzo M, Solidoro P, Del Sorbo L, Ranieri VM, Rinaldi M (2014) Incidence and severity of primary graft dysfunction after lung transplantation using rejected grafts reconditioned with ex vivo lung perfusion†. Eur J Cardiothorac Surg 46(5):789–793. https://doi.org/10.1093/ejcts/ezu239
Ceulemans LJ, Monbaliu D, Verslype C, van der Merwe S, Laleman W, Vos R, Neyrinck A, Van Veer H, De Leyn P, Nevens F, Pirenne J, Verleden G, Van Raemdonck D (2014) Combined liver and lung transplantation with extended normothermic lung preservation in a patient with end-stage emphysema complicated by drug-induced acute liver failure. Am J Transplant 14(10):2412–2416. https://doi.org/10.1111/ajt.12856
Ceulemans LJ, Neyrinck A, Loor G, Warnecke G, Villavicencio M, Madsen JC, Kukreja J, Hartwig M, Ardehali A, Huddleston S, Hertz M, Van Raemdonck D (2019) Lung transplantation from donation after circulatory death donors following portable ex-vivo lung perfusion: post-hoc analysis of OCS lung EXPAND trial. J Heart Lung Transplant 38(4):S320. https://doi.org/10.1016/j.healun.2019.01.806
Cypel M, Yeung JC, Donahoe L, Chen M, Zamel R, Hoetzenecker K, Yasufuku K, de Perrot M, Pierre AF, Waddell TK, Keshavjee S (2020) Normothermic ex vivo lung perfusion: does the indication impact organ utilization and patient outcomes after transplantation? J Thorac Cardiovasc Surg 159(1):346–355.e341. https://doi.org/10.1016/j.jtcvs.2019.06.123
Cypel M, Yeung JC, Hirayama S, Rubacha M, Fischer S, Anraku M, Sato M, Harwood S, Pierre A, Waddell TK, de Perrot M, Liu M, Keshavjee S (2008) Technique for prolonged normothermic ex vivo lung perfusion. J Heart Lung Transplant 27(12):1319–1325. https://doi.org/10.1016/j.healun.2008.09.003
Cypel M, Yeung JC, Liu M, Anraku M, Chen F, Karolak W, Sato M, Laratta J, Azad S, Madonik M, Chow CW, Chaparro C, Hutcheon M, Singer LG, Slutsky AS, Yasufuku K, de Perrot M, Pierre AF, Waddell TK, Keshavjee S (2011) Normothermic ex vivo lung perfusion in clinical lung transplantation. N Engl J Med 364(15):1431–1440. https://doi.org/10.1056/NEJMoa1014597
Del Sorbo L, Goligher EC, McAuley DF, Rubenfeld GD, Brochard LJ, Gattinoni L, Slutsky AS, Fan E (2017) Mechanical ventilation in adults with acute respiratory distress syndrome. Summary of the experimental evidence for the clinical practice guideline. Ann Am Thorac Soc 14(Supplement_4):S261–S270. https://doi.org/10.1513/AnnalsATS.201704-345OT
Divithotawela C, Cypel M, Martinu T, Singer LG, Binnie M, Chow C-W, Chaparro C, Waddell TK, de Perrot M, Pierre A, Yasufuku K, Yeung JC, Donahoe L, Keshavjee S, Tikkanen JM (2019) Long-term outcomes of lung transplant with ex vivo lung perfusion. JAMA Surg 154(12):1143–1150. https://doi.org/10.1001/jamasurg.2019.4079
European Medicines Agency: EMEA/CHMP/329441/2005 Consultation procedure Public Assessment Report (CPAR) (August 2012). https://www.ema.europa.eu/en/documents/other/consultation-ancillary-medicinal-substance-incorporated-medical-device-steen-solution_en.pdf
Ferdinand JR, Morrison MI, Andreasson A, Charlton C, Chhatwal A, Scott WE, Borthwick LA, Clatworthy MR, Fisher AJ (2019) Transcriptional analysis identifies novel biomarkers associated with successful ex-vivo perfusion of human donor lungs. bioRxiv 612374. https://doi.org/10.1101/612374
Fildes JE, Archer LD, Blaikley J, Ball AL, Stone JP, Sjöberg T, Steen S, Yonan N (2015) Clinical outcome of patients transplanted with marginal donor lungs via ex vivo lung perfusion compared to standard lung transplantation. Transplantation 99(5):1078–1083. https://doi.org/10.1097/tp.0000000000000462
Fischer S, Bohn D, Rycus P, Pierre AF, de Perrot M, Waddell TK, Keshavjee S (2007) Extracorporeal membrane oxygenation for primary graft dysfunction after lung transplantation: analysis of the Extracorporeal Life Support Organization (ELSO) registry. J Heart Lung Transplant 26(5):472–477. https://doi.org/10.1016/j.healun.2007.01.031
Fisher A, Andreasson A, Chrysos A, Lally J, Mamasoula C, Exley C, Wilkinson J, Qian J, Watson G, Lewington O, Chadwick T, McColl E, Pearce M, Mann K, McMeekin N, Vale L, Tsui S, Yonan N, Simon A, Marczin N, Mascaro J, Dark J (2016) An observational study of Donor Ex Vivo lung Perfusion in UK lung transplantation: DEVELOP-UK. Health Technol Assess 20(85):1–276. https://doi.org/10.3310/hta20850
Galasso M, Feld JJ, Watanabe Y, Pipkin M, Summers C, Ali A, Qaqish R, Chen M, Ribeiro RVP, Ramadan K, Pires L, Bagnato VS, Kurachi C, Cherepanov V, Moonen G, Gazzalle A, Waddell TK, Liu M, Keshavjee S, Wilson BC, Humar A, Cypel M (2019a) Inactivating hepatitis C virus in donor lungs using light therapies during normothermic ex vivo lung perfusion. Nat Commun 10(1):481. https://doi.org/10.1038/s41467-018-08261-z
Galasso M, Vanderlaan RD, Solomon M, Caldarone C, Keshavjee S, Cypel M, de Perrot M (2019b) A successful lung transplant from a 3-year-old donor after controlled cardiac death followed by ex vivo lung perfusion: a case report. J Thorac Cardiovasc Surg 158(4):e149–e152. https://doi.org/10.1016/j.jtcvs.2019.02.131
Ghaidan H, Fakhro M, Andreasson J, Pierre L, Ingemansson R, Lindstedt S (2019) Ten year follow-up of lung transplantations using initially rejected donor lungs after reconditioning using ex vivo lung perfusion. J Cardiothorac Surg 14(1):125–125. https://doi.org/10.1186/s13019-019-0948-1
Guenthart BA, O’Neill JD, Kim J, Queen D, Chicotka S, Fung K, Simpson M, Donocoff R, Salna M, Marboe CC, Cunningham K, Halligan SP, Wobma HM, Hozain AE, Romanov A, Vunjak-Novakovic G, Bacchetta M (2019) Regeneration of severely damaged lungs using an interventional cross-circulation platform. Nat Commun 10(1):1985. https://doi.org/10.1038/s41467-019-09908-1
Hamilton BCS, Kukreja J, Ware LB, Matthay MA (2017) Protein biomarkers associated with primary graft dysfunction following lung transplantation. Am J Physiol Lung Cell Mol Physiol 312(4):L531–L541. https://doi.org/10.1152/ajplung.00454.2016
Hashimoto K, Cypel M, Kim H, Machuca TN, Nakajima D, Chen M, Hsin MK, Zamel R, Azad S, Waddell TK, Liu M, Keshavjee S (2017) Soluble adhesion molecules during ex vivo lung perfusion are associated with posttransplant primary graft dysfunction. Am J Transplant 17(5):1396–1404. https://doi.org/10.1111/ajt.14160
Healey A, Watanabe Y, Mills C, Stoncius M, Lavery S, Johnson K, Sanderson R, Humar A, Yeung J, Donahoe L, Pierre A, de Perrot M, Yasufuku K, Waddell TK, Keshavjee S, Cypel M (2020) Initial lung transplantation experience with uncontrolled donation after cardiac death in North America. Am J Transplant 20(6):1574–1581. https://doi.org/10.1111/ajt.15795
Hopkins PM, Chambers DC, Naidoo R, Wall DA, Smith IJ, Hunt WG (2013) Australia’s experience with ex-vivo lung perfusion of highly marginal donors. J Heart Lung Transplant 32(4):S154. https://doi.org/10.1016/j.healun.2013.01.355
Hsin MK, Zamel R, Cypel M, Wishart D, Han B, Keshavjee S, Liu M (2018) Metabolic profile of ex vivo lung perfusate yields biomarkers for lung transplant outcomes. Ann Surg 267(1):196–197. https://doi.org/10.1097/sla.0000000000002016
Hsin MKY, Iskender I, Nakajima D, Chen M, Kim H, dos Santos PR, Sakamoto J, Lee J, Hashimoto K, Harmantas C, Hwang D, Waddell T, Liu M, Keshavjee S, Cypel M (2016) Extension of donor lung preservation with hypothermic storage after normothermic ex vivo lung perfusion. J Heart Lung Transplant 35(1):130–136. https://doi.org/10.1016/j.healun.2015.05.017
Iribarne A, Meltzer DO, Chauhan D, Sonett JR, Gibbons RD, Vigneswaran W, Russo MJ (2016) Distribution of donor lungs in the United States: a case for broader geographic sharing. Clin Transpl 30(6):688–693. https://doi.org/10.1111/ctr.12735
Keshavjee ST, CA), Liu, Mingyao (TORONTO, CA), Cypel, Marcelo (TORONTO, CA), Sage, Andrew (TORONTO, CA) (2020) Biomarkers in Ex Vivo Lung Perfusion (EVLP) Perfusate. United States Patent
Ku TJY, Ribeiro RVP, Ferreira VH, Galasso M, Keshavjee S, Kumar D, Cypel M, Humar A (2020) Ex-vivo delivery of monoclonal antibody (Rituximab) to treat human donor lungs prior to transplantation. EBioMedicine 60:102994. https://doi.org/10.1016/j.ebiom.2020.102994
Lee JW, Fang X, Gupta N, Serikov V, Matthay MA (2009) Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung. Proc Natl Acad Sci 106(38):16357–16362. https://doi.org/10.1073/pnas.0907996106
Leiva-Juárez MM, Urso A, Arango Tomás E, Lederer DJ, Sanchez P, Griffith B, Davis RD, Daneshmand M, Hartwig M, Cantu E, Weyant MJ, Bermudez C, D’Cunha J, Machuca T, Wozniak T, Lynch W, Nemeh H, Mulligan M, Song T, Jessen M, Camp PC, Caldeira C, Whitson B, Kreisel D, Ramzy D, D’Ovidio F (2020) Extended post-ex vivo lung perfusion cold preservation predicts primary graft dysfunction and mortality: results from a multicentric study. J Heart Lung Transplant 39(9):954–961. https://doi.org/10.1016/j.healun.2020.05.002
Lewis J, Thomas J, Roos A, Griffo ZJ (1961) Relation between alveolar surface tension and pulmonary vascular resistance. J Appl Physiol 16(3):457–462. https://doi.org/10.1152/jappl.1961.16.3.457
Linacre V, Cypel M, Machuca T, Nakajima D, Hashimoto K, Zamel R, Chen M, Iskender I, Dos Santos P, Waddell TK, Liu M, Keshavjee S (2016) Importance of left atrial pressure during ex vivo lung perfusion. J Heart Lung Transplant 35(6):808–814. https://doi.org/10.1016/j.healun.2016.02.008
Loor G, Parulekar A, Smith M (2019a) Evaluation of the INSPIRE trial and its implications for lung transplantation with normothermic portable ex vivo lung perfusion. J Thorac Cardiovasc Surg 158(4):1259–1263. https://doi.org/10.1016/j.jtcvs.2019.02.139
Loor G, Warnecke G, Villavicencio MA, Smith MA, Kukreja J, Ardehali A, Hartwig M, Daneshmand MA, Hertz MI, Huddleston S, Haverich A, Madsen JC, Van Raemdonck D (2019b) Portable normothermic ex-vivo lung perfusion, ventilation, and functional assessment with the Organ Care System on donor lung use for transplantation from extended-criteria donors (EXPAND): a single-arm, pivotal trial. Lancet Respir Med 7(11):975–984. https://doi.org/10.1016/S2213-2600(19)30200-0
Luc JGY, Jackson K, Weinkauf JG, Freed DH, Nagendran J (2017) Feasibility of lung transplantation from donation after circulatory death donors following portable ex vivo lung perfusion: a pilot study. Transplant Proc 49(8):1885–1892. https://doi.org/10.1016/j.transproceed.2017.04.010
Machuca TN, Mercier O, Collaud S, Tikkanen J, Krueger T, Yeung JC, Chen M, Azad S, Singer L, Yasufuku K, de Perrot M, Pierre A, Waddell TK, Keshavjee S, Cypel M (2015) Lung transplantation with donation after circulatory determination of death donors and the impact of ex vivo lung perfusion. Am J Transplant 15(4):993–1002. https://doi.org/10.1111/ajt.13124
Mehaffey JH, Charles EJ, Schubert S, Salmon M, Sharma AK, Money D, Stoler MH, Laubach VE, Tribble CG, Roeser ME, Kron IL (2018) In vivo lung perfusion rehabilitates sepsis-induced lung injury. J Thorac Cardiovasc Surg 155(1):440–448.e442. https://doi.org/10.1016/j.jtcvs.2017.08.124
Mehaffey JH, Charles EJ, Sharma AK, Money DT, Zhao Y, Stoler MH, Lau CL, Tribble CG, Laubach VE, Roeser ME, Kron IL (2017) Airway pressure release ventilation during ex vivo lung perfusion attenuates injury. J Thorac Cardiovasc Surg 153(1):197–204. https://doi.org/10.1016/j.jtcvs.2016.09.029
Mooney JJ, Bhattacharya J, Dhillon GS (2019) Effect of broader geographic sharing of donor lungs on lung transplant waitlist outcomes. J Heart Lung Transplant 38(2):136–144. https://doi.org/10.1016/j.healun.2018.09.007
Mooney JJ, Hedlin H, Mohabir PK, Vazquez R, Nguyen J, Ha R, Chiu P, Patel K, Zamora MR, Weill D, Nicolls MR, Dhillon GS (2016) Lung quality and utilization in controlled donation after circulatory determination of death within the United States. Am J Transplant 16(4):1207–1215. https://doi.org/10.1111/ajt.13599
Niikawa H, Okamoto T, Ayyat KS, Itoda Y, Farver CF, McCurry KR (2019) The protective effect of prone lung position on ischemia-reperfusion injury and lung function in an ex vivo porcine lung model. J Thorac Cardiovasc Surg 157(1):425–433. https://doi.org/10.1016/j.jtcvs.2018.08.101
Nilsson T, Wallinder A, Henriksen I, Nilsson JC, Ricksten S-E, Møller-Sørensen H, Riise GC, Perch M, Dellgren G (2018) Lung transplantation after ex vivo lung perfusion in two Scandinavian centres. Eur J Cardiothorac Surg 55(4):766–772. https://doi.org/10.1093/ejcts/ezy354
Noda K, Tane S, Haam SJ, Hayanga AJ, D’Cunha J, Luketich JD, Shigemura N (2017) Optimal ex vivo lung perfusion techniques with oxygenated perfusate. J Heart Lung Transplant 36(4):466–474. https://doi.org/10.1016/j.healun.2016.10.014
Okahara S, Levvey B, McDonald M, D’Costa R, Opdam H, Pilcher DV, Snell GI (2020) Common criteria for ex-vivo lung perfusion have no significant impact on post-transplant outcomes. Ann Thorac Surg. https://doi.org/10.1016/j.athoracsur.2020.06.081
Ordies S, Frick AE, Claes S, Schols D, Verleden SE, Van Raemdonck DE, Neyrinck AP (2019) Prone positioning during ex vivo lung perfusion influences regional edema accumulation. J Surg Res 239:300–308. https://doi.org/10.1016/j.jss.2019.02.003
Sage E, Mussot S, Trebbia G, Puyo P, Stern M, Dartevelle P, Chapelier A, Fischler M, Foch Lung Transplant G (2014) Lung transplantation from initially rejected donors after ex vivo lung reconditioning: the French experience. Eur J Cardiothorac Surg 46(5):794–799. https://doi.org/10.1093/ejcts/ezu245
Sanchez PG, Cantu E, Hartwig M, D’Ovidio F, Machuca T, Whitson B, Daneshmand M, Bermudez C, Mulligan M, D’Cunha J, Weyant M, Lynch W, Garcia J, Caldeira C, Nemeh H, Song T, Kreisel D, Jessen M, Camp P, Ramzy D, Griffith B, Davis D (2020) The NOVEL study. A multi-center clinical trial studying the safety of ex vivo lung perfusion. J Heart Lung Transplant 39(4, Supplement):S110. https://doi.org/10.1016/j.healun.2020.01.977
Sanchez PG, Davis RD, D’Ovidio F, Cantu E, Weyant M, Camp P, Griffith BP (2014) The NOVEL lung trial one-year outcomes. J Heart Lung Transplant 33(4):S71–S72. https://doi.org/10.1016/j.healun.2014.01.226
Slama A, Schillab L, Barta M, Benedek A, Mitterbauer A, Hoetzenecker K, Taghavi S, Lang G, Matilla J, Ankersmit H, Hager H, Roth G, Klepetko W, Aigner C (2017) Standard donor lung procurement with normothermic ex vivo lung perfusion: a prospective randomized clinical trial. J Heart Lung Transplant 36(7):744–753. https://doi.org/10.1016/j.healun.2017.02.011
Steen S, Sjöberg T, Pierre L, Liao Q, Eriksson L, Algotsson L (2001) Transplantation of lungs from a non-heart-beating donor. Lancet 357(9259):825–829. https://doi.org/10.1016/S0140-6736(00)04195-7
Stone JP, Critchley WR, Major T, Rajan G, Risnes I, Scott H, Liao Q, Wohlfart B, Sjöberg T, Yonan N, Steen S, Fildes JE (2016) Altered immunogenicity of donor lungs via removal of passenger leukocytes using ex vivo lung perfusion. Am J Transplant 16(1):33–43. https://doi.org/10.1111/ajt.13446
Tanaka Y, Noda K, Isse K, Tobita K, Maniwa Y, Bhama JK, D’Cunha J, Bermudez CA, Luketich JD, Shigemura N (2015) A novel dual ex vivo lung perfusion technique improves immediate outcomes in an experimental model of lung transplantation. Am J Transplant 15(5):1219–1230. https://doi.org/10.1111/ajt.13109
Tane S, Noda K, Shigemura N (2017) Ex vivo lung perfusion: a key tool for translational science in the lungs. Chest 151(6):1220–1228. https://doi.org/10.1016/j.chest.2017.02.018
Terragni PPMD, Fanelli VMD, Boffini MMD, Filippini CP, Cappello PP, Ricci DMD, Del Sorbo LMD, Faggiano CMD, Brazzi LP, Frati GMD, Venuta FMD, Mascia LMDP, Rinaldi MMD, Ranieri VMMD (2016) Ventilatory management during Normothermic ex vivo lung perfusion: effects on clinical outcomes. Transplantation 100(5):1128–1135
Valdivia D, Gómez de Antonio D, Hoyos L, Campo-Cañaveral de la Cruz JL, Romero A, Varela de Ugarte A (2019) Expanding the horizons: uncontrolled donors after circulatory death for lung transplantation – first comparison with brain death donors. Clin Transpl 33(6):e13561. https://doi.org/10.1111/ctr.13561
Wallinder A (2014) Ex vivo lung perfusion-clinical and experimental studies. Sahlgrenska Academy, University of Gothenburg, Göteborg
Wallinder A, Ricksten S-E, Hansson C, Riise GC, Silverborn M, Liden H, Olausson M, Dellgren G (2012) Transplantation of initially rejected donor lungs after ex vivo lung perfusion. J Thorac Cardiovasc Surg 144(5):1222–1228. https://doi.org/10.1016/j.jtcvs.2012.08.011
Wallinder A, Riise GC, Ricksten SE, Silverborn M, Dellgren G (2016) Transplantation after ex vivo lung perfusion: a midterm follow-up. J Heart Lung Transplant 35(11):1303–1310. https://doi.org/10.1016/j.healun.2016.05.021
Warnecke G, Moradiellos J, Tudorache I, Kuhn C, Avsar M, Wiegmann B, Sommer W, Ius F, Kunze C, Gottlieb J, Varela A, Haverich A (2012) Normothermic perfusion of donor lungs for preservation and assessment with the Organ Care System Lung before bilateral transplantation: a pilot study of 12 patients. Lancet 380(9856):1851–1858. https://doi.org/10.1016/S0140-6736(12)61344-0
Whitson BA, Shukrallah B, Mulligan MS, D’Cunha J, Daneshmand M, Wozniak T, Kon Z, Machuca T, Jessen M, Sanchez P, Cantu E (2018) Ex-vivo lung perfusion in donation after circulatory death lung transplantation increases donor utilization: analysis of the NOVEL extension trial. J Heart Lung Transplant 37(4):S147–S148. https://doi.org/10.1016/j.healun.2018.01.358
Yeung JC, Krueger T, Yasufuku K, de Perrot M, Pierre AF, Waddell TK, Singer LG, Keshavjee S, Cypel M (2017) Outcomes after transplantation of lungs preserved for more than 12 h: a retrospective study. Lancet Respir Med 5(2):119–124. https://doi.org/10.1016/s2213-2600(16)30323-x
Zeriouh M, Sabashnikov A, Mohite PN, Zych B, Patil NP, Garcia-Saez D, Koch A, Weymann A, Soresi S, Wippermann J, Wahlers T, De Robertis F, Popov AF, Simon AR (2016) Utilization of the organ care system for bilateral lung transplantation: preliminary results of a comparative study. Interact Cardiovasc Thorac Surg 23(3):351–357. https://doi.org/10.1093/icvts/ivw135
Zhang ZL, van Suylen V, van Zanden JE, Van De Wauwer C, Verschuuren EAM, van der Bij W, Erasmus ME (2019) First experience with ex vivo lung perfusion for initially discarded donor lungs in the Netherlands: a single-centre study. Eur J Cardiothorac Surg 55(5):920–926. https://doi.org/10.1093/ejcts/ezy373
Zych B, Popov AF, Stavri G, Bashford A, Bahrami T, Amrani M, De Robertis F, Carby M, Marczin N, Simon AR, Redmond KC (2012) Early outcomes of bilateral sequential single lung transplantation after ex-vivo lung evaluation and reconditioning. J Heart Lung Transplant 31(3):274–281. https://doi.org/10.1016/j.healun.2011.10.008
Acknowledgments
We thank Dr. Shannon L. Wyszomierski for editing the book chapter.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Electronic Supplementary Material
LA back flow in lungs on EVLP with the Lund protocol. Swine lungs were placed on an LS-1 machine and perfused with 100% of cardiac output. The flow coming back from the pulmonary vein makes a fountain shape of perfusate and creates positive pressure in the pulmonary vein. (This video was kindly provided by Mr. Rodney Jones (XVIVO Perfusion) and is used with permission) (MP4 7447 kb)
Rights and permissions
Copyright information
© 2021 UPMC Italy S.R.L.
About this entry
Cite this entry
Noda, K., Sanchez, P.G. (2021). Ex Vivo Lung Perfusion: Promises and Reality. In: Bertani, A., Vitulo, P., Grossi, P.A. (eds) Contemporary Lung Transplantation. Organ and Tissue Transplantation. Springer, Cham. https://doi.org/10.1007/978-3-319-20788-9_23-1
Download citation
DOI: https://doi.org/10.1007/978-3-319-20788-9_23-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-20788-9
Online ISBN: 978-3-319-20788-9
eBook Packages: Springer Reference MedicineReference Module Medicine